Voleon Capital Management LP Purchases New Stake in Alignment Healthcare, Inc. $ALHC

Key Points

• Voleon Capital Management invested approximately $426,000 in Alignment Healthcare by purchasing 22,893 shares, according to its recent SEC filing.
• Multiple institutional investors have significantly increased their stakes in Alignment Healthcare, with Wellington Management Group and Millennium Management boosting their holdings by 77.9% and 588.3%, respectively.
• Alignment Healthcare's stock has shown a 1.6% increase recently, while its quarterly earnings report revealed a revenue of $1.02 billion, surpassing analyst expectations of $960.25 million.

Voleon Capital Management LP acquired a new position in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) during the 1st quarter, according to its most recent 13F filing with the SEC. The fund acquired 22,893 shares of the company's stock, valued at approximately $426,000.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. MCF Advisors LLC increased its holdings in shares of Alignment Healthcare by 87.6% in the 1st quarter. MCF Advisors LLC now owns 2,165 shares of the company's stock valued at $40,000 after acquiring an additional 1,011 shares during the last quarter. Skandinaviska Enskilda Banken AB publ bought a new stake in shares of Alignment Healthcare in the 1st quarter valued at approximately $42,000. Amalgamated Bank increased its holdings in shares of Alignment Healthcare by 21.6% in the 1st quarter. Amalgamated Bank now owns 3,466 shares of the company's stock valued at $65,000 after acquiring an additional 616 shares during the last quarter. Voloridge Investment Management LLC bought a new stake in shares of Alignment Healthcare in the 4th quarter valued at approximately $189,000. Finally, Regal Partners Ltd bought a new position in Alignment Healthcare during the 1st quarter worth $194,000. 86.19% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

ALHC has been the subject of a number of recent research reports. Barclays upgraded Alignment Healthcare from an "underweight" rating to an "equal weight" rating and upped their price objective for the stock from $9.00 to $13.00 in a research note on Thursday, July 31st. Wall Street Zen downgraded Alignment Healthcare from a "buy" rating to a "hold" rating in a research note on Sunday, August 10th. Stephens upgraded Alignment Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Zacks Research upgraded Alignment Healthcare to a "hold" rating in a research report on Friday, August 8th. Finally, KeyCorp upgraded Alignment Healthcare from a "sector weight" rating to an "overweight" rating and set a $21.00 price target for the company in a research report on Monday, August 25th. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and four have given a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $18.83.

Alignment Healthcare Trading Up 2.7%

Shares of Alignment Healthcare stock traded up $0.43 on Monday, reaching $16.47. 1,143,991 shares of the company were exchanged, compared to its average volume of 3,100,660. The stock has a fifty day moving average price of $14.40 and a 200-day moving average price of $15.54. The firm has a market capitalization of $3.26 billion, a price-to-earnings ratio of -58.94 and a beta of 1.17. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 2.29. Alignment Healthcare, Inc. has a fifty-two week low of $9.15 and a fifty-two week high of $21.06.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last announced its earnings results on Wednesday, July 30th. The company reported $0.07 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.07) by $0.14. The company had revenue of $1.02 billion for the quarter, compared to analyst estimates of $960.25 million. Alignment Healthcare had a negative return on equity of 43.68% and a negative net margin of 1.53%.Alignment Healthcare's revenue for the quarter was up 49.0% compared to the same quarter last year. During the same period in the previous year, the firm earned ($0.13) earnings per share. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. On average, analysts expect that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Insider Activity at Alignment Healthcare

In other news, insider Christopher J. Joyce sold 30,939 shares of the business's stock in a transaction on Wednesday, September 10th. The stock was sold at an average price of $16.41, for a total transaction of $507,708.99. Following the sale, the insider directly owned 343,592 shares of the company's stock, valued at $5,638,344.72. The trade was a 8.26% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO John E. Kao sold 355,018 shares of the business's stock in a transaction on Wednesday, September 10th. The stock was sold at an average price of $16.41, for a total value of $5,825,845.38. Following the sale, the chief executive officer directly owned 4,533,568 shares in the company, valued at $74,395,850.88. This trade represents a 7.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 1,142,077 shares of company stock valued at $18,068,259 over the last ninety days. Company insiders own 6.60% of the company's stock.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.